|
ZDHHC4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.6505464489901E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.33460045634604E-10 |
| Normal-vs-Stage2 |
2.188000E-02 |
| Normal-vs-Stage3 |
4.150600E-01 |
| Normal-vs-Stage4 |
3.931000E-01 |
| Stage1-vs-Stage2 |
4.234200E-01 |
| Stage1-vs-Stage3 |
1.472090E-02 |
| Stage1-vs-Stage4 |
3.495600E-01 |
| Stage2-vs-Stage3 |
2.043800E-01 |
| Stage2-vs-Stage4 |
7.497200E-01 |
| Stage3-vs-Stage4 |
5.764800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.25800481143301E-11 |
| Normal-vs-AfricanAmerican |
2.48559999999065E-05 |
| Normal-vs-Asian |
7.982800E-01 |
| Caucasian-vs-AfricanAmerican |
7.900200E-01 |
| Caucasian-vs-Asian |
3.106400E-01 |
| AfricanAmerican-vs-Asian |
5.845200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.07434069920964E-12 |
| Normal-vs-Female |
1.964680E-04 |
| Male-vs-Female |
1.145240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.344600E-03 |
| Normal-vs-Extreme_Weight |
7.86149999543184E-08 |
| Normal-vs-Obese |
5.75859999999428E-05 |
| Normal-vs-Extreme_Obese |
2.854600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.142600E-01 |
| Normal_Weight-vs-Obese |
7.718000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.286200E-01 |
| Extreme_Weight-vs-Obese |
2.594800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.976400E-01 |
| Obese-vs-Extreme_Obese |
5.687200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.731900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.45490003272886E-09 |
| Normal-vs-Age(61-80Yrs) |
1.08530000542117E-08 |
| Normal-vs-Age(81-100Yrs) |
1.462240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.504000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.665400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.749200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.773400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.288200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.899200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
2.762000E-01 |
| Normal-VS-KIRP CIMP |
9.075900E-02 |
| Normal-VS-Unclassified PRCC |
7.741100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.74779995926389E-09 |
| Type1 PRCC-VS-KIRP CIMP |
8.21480000023911E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
9.636600E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.246400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.238200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.424460E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.005800E-02 |
| Normal-vs-N1 |
9.370000E-01 |
| Normal-vs-N2 |
8.875800E-01 |
| N0-vs-N1 |
1.417210E-01 |
| N0-vs-N2 |
4.647500E-02 |
| N1-vs-N2 |
9.305800E-01 |
|
|
